ORMD-0801 Dose # 1
ORA-D-009
Phase 2 small_molecule completed
Quick answer
ORMD-0801 Dose # 1 for Diabetes Mellitus Type 2 is a Phase 2 program (small_molecule) at ORAMED PHARMACEUTICALS INC. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- ORAMED PHARMACEUTICALS INC.
- Indication
- Diabetes Mellitus Type 2
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed